RADIX PHARMACEUTICALS, INC.

Company Information

Company Name
RADIX PHARMACEUTICALS, INC.
Address
13303 Sunny Brooke Place
Room 101
Potomac, MD, -
Phone
n/a
URL
n/a
DUNS
142006910
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$1,590,508.00
4
SBIR Phase II
$2,843,317.00
3

Award List

  1. Synthesis and Evaluation of Novel Antimalarial Agents

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this research is to develop drugs that are safe and effective against drug-resistant malaria. Malaria is one of the most common infectious di ...

    SBIR Phase I 2005 Department of Health and Human Services
  2. Pre-Clinical Development of Natural Product Analogues as Antimalarial Agents

    Amount: $604,800.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIR Phase II 2006 Department of Health and Human Services
  3. Development of Natural Product as Antimalarial Agent

    Amount: $299,880.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIR Phase I 2007 Department of Health and Human Services
  4. Isolation and Antimalarial Activity of Small Molecules from Ocimum sanctum

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIR Phase I 2008 Department of Health and Human Services
  5. Pre-Clinical Evaluation of Antimalarial Natural Products from Carica papaya L.

    Amount: $590,628.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a new drug (new chemical entity [NCE]) that is inexpensive, orally active, non-toxic and can provide cure for P. f ...

    SBIR Phase I 2008 Department of Health and Human Services
  6. Preclinical Studies of Natural Product Derivatives as Antimalarial Agents

    Amount: $998,181.00

    DESCRIPTION (provided by applicant): This project focuses on the development of a novel therapeutic agent for preventing and treating P. falciparum malaria. A two-year Phase I research has discovered ...

    SBIR Phase II 2011 Department of Health and Human Services
  7. Development of Small Molecules as Antiprotozoal Agents

    Amount: $1,240,336.00

    DESCRIPTION (provided by applicant): The proposed research focuses on the development of novel therapeutic agents for the prevention and treatment of malaria caused by P. falciparum. A previous Phase ...

    SBIR Phase II 2012 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government